Insider Shareholders with Direct Ownership of Inozyme Pharma, Inc. (INZY)
This section provides a comprehensive overview of the insiders with direct ownership of Inozyme Pharma, Inc. (INZY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Inozyme Pharma, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,569,379 | 375,000 | 2,194,379 $6.56 Million | 2 |
Jan 28, 2021
Reduced 14.59%
|
| 142,659 | 66,788 | 266,696 $797,421 | 5 |
Mar 31, 2023
Added 1.77%
|
|
|
Henric Bjorn Bjarke
SVP, COO |
51,915 | 0 | 105,441 $315,268 | 3 |
Dec 15, 2022
Added 16.94%
|
|
Sanjay Subramanian
SVP, CFO |
30,398 | 0 | 30,398 $90,890 | 3 |
Sep 29, 2023
Added 7.09%
|
|
Douglas A Treco
CEO |
26,710 | 7,523 | 22,375 $66,901 | 3 |
Sep 30, 2024
Added 7.1%
|
|
Matthew Winton
COO |
4,898 | 0 | 4,898 $14,645 | 2 |
Sep 30, 2024
Added 25.88%
|